Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 216 entries
View as:

Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01348919 Org: User:
Start: 08/03/11 End: 03/14/13 Due: 03/14/14

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00696332 Org: User:
Start: 09/30/08 End: 05/31/10 Due: 05/31/11

A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

Phase: N/A Priority: Normal
NCT ID: NCT06625177 Org: User:
Start: 11/11/24 End: 06/05/27 Due: 06/05/28

Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00982150 Org: User:
Start: 09/30/09 End: 06/30/10 Due: 06/30/11

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06480552 Org: User:
Start: 07/22/24 End: 02/25/31 Due: 02/25/32

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

Phase: N/A Priority: Normal
NCT ID: NCT01803555 Org: User:
Start: 07/04/13 End: 03/20/14 Due: 03/20/15

A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

Phase: N/A Priority: Normal
NCT ID: NCT00964730 Org: User:
Start: 10/31/09 End: 02/28/10 Due: 02/28/11

Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01032486 Org: User:
Start: 12/31/09 End: 07/31/11 Due: 07/31/12

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00071539 Org: User:
Start: 10/31/03 End: 07/31/06 Due: 07/31/07

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

Phase: N/A Priority: Normal
NCT ID: NCT00094016 Org: User:
Start: 10/31/04 End: 06/30/06 Due: 06/30/07

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Phase: N/A Priority: Normal
NCT ID: NCT02964338 Org: User:
Start: 01/17/17 End: 07/18/18 Due: 07/18/19

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00991510 Org: User:
Start: 08/31/09 End: 10/31/10 Due: 10/31/11

A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Phase: N/A Priority: Normal
NCT ID: NCT02078960 Org: User:
Start: 10/09/14 End: 11/27/17 Due: 11/27/18

Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT00509145 Org: User:
Start: 11/13/07 End: 11/08/10 Due: 11/08/11

Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT06290102 Org: User:
Start: 05/07/24 End: 10/07/24 Due: 10/07/25

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00936676 Org: User:
Start: 07/31/09 End: 03/31/13 Due: 03/31/14

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Phase: N/A Priority: Normal
NCT ID: NCT00349193 Org: User:
Start: 03/31/05 End: 08/31/06 Due: 08/31/07

Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)

Phase: N/A Priority: Normal
NCT ID: NCT01134705 Org: User:
Start: 05/31/10 End: 10/31/10 Due: 10/31/11

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT01624480 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01887366 Org: User:
Start: 06/30/13 End: 10/31/14 Due: 10/31/15

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02315144 Org: User:
Start: 04/30/15 End: 08/31/15 Due: 08/31/16

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Phase: N/A Priority: Normal
NCT ID: NCT01223365 Org: User:
Start: 10/31/10 End: 09/30/12 Due: 09/30/13

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03893825 Org: User:
Start: 04/17/19 End: 12/02/21 Due: 12/02/22

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01085084 Org: User:
Start: 10/04/10 End: 11/12/12 Due: 11/12/13

Multicenter Trial For Patients With Acute Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00035503 Org: User:
Start: 01/31/02 End: 01/31/04 Due: 01/31/05